Insmed Reports Second Quarter 2022 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Insmed (INSM) Tops Q2 EPS by 9c
August 4, 2022 7:35 AM EDTInsmed (NASDAQ: INSM) reported Q2 EPS of ($0.80), $0.09 better than the analyst estimate of ($0.89). Revenue for the quarter came in at $65.2 million versus the consensus estimate of $58.79 million.
As of June 30, 2022, Insmed had cash and cash equivalents and marketable securities of $564.6 million. The... More
